Sanders Linda M, Dardik Michael, Modi Lopa, Sanders Alison Esteva, Schaefer Sarah S, Litvak Anya
Department of Radiology, St Barnabas Medical Center, Livingston, NJ, USA.
Department of Pathology, St Barnabas Medical Center, Livingston, NJ, USA.
SAGE Open Med Case Rep. 2017 Apr 21;5:2050313X17705803. doi: 10.1177/2050313X17705803. eCollection 2017.
Lymphovascular invasion (LVI) is a pathologic, microscopic finding associated with invasive cancer, and is a poor prognostic indicator, but has no reported imaging findings. This report presents the first documented case of LVI with seen by imaging. Linear branching microcalcifications were identified on mammography and clumped enhancement was noted on MRI, both imaging findings that are highly predictive of ductal carcinoma in situ (DCIS).
Ultrasound guided core biopsy of the dominant mass was performed, confirming invasive ductal malignancy. Stereotactic biopsy performed on the microcalcifications was initially interpreted by pathology as DCIS.
Patient underwent mastectomy. Pathologic evaluation of the surgical specimen confirmed the invasive ductal malignancy. Microcalcifications were re-evaluated with immunohistochemistry (IHC) and re-classified as LVI. Radiology images and IHC stains are shown.
This is the first report of LVI identified by imaging with findings that mimicked DCIS and initially mis-identified as DCIS by pathology as well. The implications of this overlap in radiologic appearance are discussed.
淋巴管浸润(LVI)是一种与浸润性癌相关的病理学微观表现,是预后不良的指标,但尚无影像学表现的报道。本报告展示了首例经影像学发现的LVI病例。乳腺钼靶检查发现线性分支状微钙化,磁共振成像(MRI)显示团状强化,这两种影像学表现都高度提示导管原位癌(DCIS)。
对主要肿块进行超声引导下的粗针活检,确诊为浸润性导管恶性肿瘤。对微钙化进行的立体定向活检最初经病理诊断为DCIS。
患者接受了乳房切除术。手术标本的病理评估证实为浸润性导管恶性肿瘤。通过免疫组织化学(IHC)对微钙化进行重新评估,并重新分类为LVI。展示了放射学图像和IHC染色结果。
这是首例通过影像学发现LVI的报告,其表现类似于DCIS,最初病理也误诊为DCIS。讨论了这种影像学表现重叠的意义。